Prevalence and associations of antibiotic resistance and biofilm formation with molecular determinants in clinical Acinetobacter baumannii isolates.

Ayat M Abu-Resha, Hazem H Saleh, Mohamed I Abou-Dobara, Ahmed K El-Sayed

Abstract read

In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayat M Abu-ReshaBotany and Microbiology Department, Faculty of Science, Damietta University, PO 34517, New Damietta City, Egypt.

Hazem H SalehUrology and Nephrology Center, Mansoura University, Mansoura, Egypt.

Mohamed I Abou-DobaraBotany and Microbiology Department, Faculty of Science, Damietta University, PO 34517, New Damietta City, Egypt.

Ahmed K El-SayedBotany and Microbiology Department, Faculty of Science, Damietta University, PO 34517, New Damietta City, Egypt. akaelsayed@du.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acinetobacter baumannii is a notorious opportunistic pathogen commonly associated with healthcare-associated infections and multidrug resistance. Its survival in hospital environments, biofilm formation, and iron acquisition systems complicate treatment. Understanding virulence factors and resistance mechanisms is crucial for developing effective control strategies. This study investigates genetic determinants of virulence and antibiotic resistance in selected MDR/XDR clinical A. baumannii isolates and explores their relationship with phenotypic traits. The selected MDR/XDR clinical A. baumannii isolates were identified using standard microbiological methods. Antimicrobial susceptibility followed CLSI guidelines. Biofilm formation was assessed using the tissue culture plate method. Molecular confirmation and detection of the selected genes were performed by multiplex PCR. In this study, 150 non-duplicate MDR/XDR clinical A. baumannii isolates were selectively collected from routine laboratory records based on their resistance profiles. Among the selected isolates, (84%) were XDR and (16%) were MDR. bla

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBiofilmsDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesHumansMicrobial Sensitivity TestsPrevalenceVirulence FactorsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesVirulence FactorsA. baumanniiBiofilm formationCarbapenemase genesMultiplex PCRXDR/MDR

Identifiers

PMID42575915

DOI10.1038/s41598-026-64464-1

PMCPMC13458683

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.